ArticleBritish journal of cancer2025

Semi-mechanistic efficacy model for PARP + ATR inhibitors-application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXs.

Claire C Villette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.